Bill Welch

Directeur/Membre du Conseil chez Serimmune, Inc.

Profil

William J.
Welch currently works at Abbott Ventures, Inc., as Director-Finance from 2010, Serimmune, Inc., as Director from 2019, Skydeck Associates LLC, as Managing Director from 2010, and IIF Management Co. LLC, as Venture Partner from 2019.
Mr. Welch also formerly worked at Sequenom, Inc., as President, Chief Executive Officer & Director in 2015, Cardiff Oncology, Inc., as President and Chief Executive Officer from 2016 to 2018, Cardiff Oncology, Inc., as Chief Executive Officer in 2016, Abbott Laboratories, as GM-Ambulatory Infusion Systems Division from 1993 to 1998, La Jolla Pharmaceutical Co., as Vice President-Sales & Marketing from 2001 to 2005, La Jolla Pharmaceutical Co., as Vice President-Sales & Marketing from 1998 to 1999, Monogram Biosciences, Inc., as Chief Commercial Officer & Senior Vice President from 2005 to 2009, and Dade Behring Holdings, Inc., as Senior Vice President-Global Sales & Marketing from 1999 to 2001.
Mr. Welch received his Masters Business Admin degree in 1986 from Harvard University and undergraduate degree in 1984 from the University of California, Berkeley.

Postes actifs de Bill Welch

Sociétés	Poste	Début
Serimmune, Inc.	Directeur/Membre du Conseil	01/06/2019
Abbott Ventures, Inc.	Directeur/Membre du Conseil	01/06/2010
IIF Management Co. LLC	Private Equity Investor	01/04/2019
Skydeck Associates LLC	Directeur/Membre du Conseil	01/01/2010

Anciens postes connus de Bill Welch

Sociétés	Poste	Fin
CARDIFF ONCOLOGY, INC.	Directeur Général	22/06/2018
CARDIFF ONCOLOGY, INC.	Directeur Général	01/06/2018
SEQUENOM, INC.	Directeur Général	21/09/2015
Monogram Biosciences, Inc.	Private Equity Investor	01/01/2009
LA JOLLA PHARMACEUTICAL COMPANY	Sales & Marketing	01/09/2005

Formation de Bill Welch

Harvard University	Masters Business Admin
University of California, Berkeley	Undergraduate Degree